ストックスクリーナーアプリを入手
13.35
0.82%
-0.11
アフターアワーズ：
13.35
前日終値:
$13.46
開ける：
$13.4
24時間の取引高:
3.76M
Relative Volume:
0.64
時価総額：
$7.10B
収益：
$4.45B
当期純損益:
$205.00M
株価収益率:
33.38
EPS:
0.4
ネットキャッシュフロー:
$372.00M
1週間 パフォーマンス:
-4.57%
1か月 パフォーマンス:
+5.45%
6か月 パフォーマンス:
+12.56%
1年 パフォーマンス:
-26.04%
1日の値動き範囲:
$13.15
$13.50
1週間の範囲:
$13.15
$13.98
52週間の値動き範囲:
$8.02
$18.55
Elanco Animal Health Inc Stock (ELAN) Company Profile
名前
Elanco Animal Health Inc
セクター
電話
877-352-6261
住所
2500 INNOVATION WAY, GREENFIELD
ELAN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
13.35 | 7.10B | 4.45B | 205.00M | 372.00M | 0.40 |
|
RGC
Regencell Bioscience Holdings Ltd
|
23.70 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
157.34 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.49 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.97 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-09 | 開始されました | UBS | Buy |
| 2024-12-02 | 開始されました | Leerink Partners | Market Perform |
| 2024-09-19 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | アップグレード | Stifel | Hold → Buy |
| 2023-12-19 | 開始されました | Jefferies | Buy |
| 2023-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 開始されました | Exane BNP Paribas | Outperform |
| 2023-04-20 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-08-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-07-21 | ダウングレード | Goldman | Buy → Sell |
| 2022-07-12 | 開始されました | Piper Sandler | Neutral |
| 2021-11-18 | 開始されました | Morgan Stanley | Overweight |
| 2021-10-28 | ダウングレード | Stifel | Buy → Hold |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-06-15 | アップグレード | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2021-05-11 | アップグレード | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 開始されました | Stifel | Buy |
| 2021-03-22 | ダウングレード | Gabelli & Co | Buy → Hold |
| 2021-02-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | ダウングレード | Argus | Buy → Hold |
| 2020-11-09 | ダウングレード | Barclays | Overweight → Underweight |
| 2020-08-20 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 再開されました | Credit Suisse | Neutral |
| 2020-08-04 | 再開されました | Goldman | Buy |
| 2020-07-27 | ダウングレード | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 開始されました | Raymond James | Mkt Perform |
| 2019-12-19 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 開始されました | Barclays | Overweight |
| 2019-08-26 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | アップグレード | UBS | Sell → Neutral |
| 2019-05-23 | 開始されました | Guggenheim | Neutral |
| 2019-03-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 再開されました | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 開始されました | William Blair | Mkt Perform |
| 2019-01-23 | 開始されました | UBS | Sell |
| 2019-01-15 | 開始されました | Argus | Buy |
| 2018-10-15 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Elanco Animal Health Inc (ELAN) 最新ニュース
Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded. - Barron's
Elanco (ELAN) Gains Attention Amid Competitive Market Shifts | E - GuruFocus
United States Veterinary Pain Management Market Size, Share & - openPR.com
Harbor Capital Advisors Inc. Has $9.41 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from - GuruFocus
Elanco (ELAN) Awaits European Approval for Zenrelia in Dogs - GuruFocus
Elanco gains positive EMA opinion for Zenrelia for itching in dogs - Seeking Alpha
Elanco (ELAN) Awaits EU Approval for Veterinary Drug Zenrelia | ELAN Stock News - GuruFocus
Elanco’s dog allergy treatment Zenrelia gets positive EU opinion By Investing.com - Investing.com Canada
Elanco Gets 'Positive Opinion' on Canine Itch Drug From European Medicines Agency - marketscreener.com
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) | ELAN Stock News - GuruFocus
Elanco Receives Positive Opinion On Zenrelia From EU's Committee - MarketScreener
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) – Company AnnouncementFT.com - Financial Times
BiomEdit CEO: Next gen designer probiotics will disrupt the animal and human health market - AgFunderNews
Elanco Animal Health Incorporated (NYSE:ELAN) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
ELAN Q1 Earnings Call: Innovation and Product Launches Drive Outlook Amid Macro Uncertainty - Yahoo Finance
Elanco Animal Health Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Dog Owner Defends Tick Meds Suit Against Elanco, Retailers - Law360
What Makes Elanco Animal Health (ELAN) a New Buy Stock - Yahoo Finance
Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Is the Options Market Predicting a Spike in Elanco Animal Health Stock? - Yahoo Finance
Veterinary Vaccines Market Set to Surge as Global Demand - openPR.com
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of “Hold” by Analysts - Defense World
Report reveals widespread impact of chronic itch in dogs - Veterinary Practice News
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief - ACCESS Newswire
Elanco Animal Health Appoints Robert VanHimbergen as Chief Financial Officer - Pet Age
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief | ELAN Stock News - GuruFocus
Sanders Morris Harris LLC Purchases 81,750 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Equine Healthcare Market Analysis: Trends, Key Players, - openPR.com
Animal Depression Medication Market Detailed in New Research Report | Zoetis Inc., Elanco Animal Health - openPR.com
Ameriprise Financial Inc. Has $1.18 Million Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Companion Animal Health Market -Depth Analysis, Future Trends - openPR.com
Veterinary Vaccines Market Size, Share & Forecast 2025-2033 | - openPR.com
Cetera Investment Advisers Purchases 4,553 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World
Elanco at Stifel Jaws & Paws: Strategic Growth and Innovation By Investing.com - Investing.com Canada
Elanco appoints Robert VanHimbergen as chief financial officer - Feed Strategy
Elanco appoints VanHimbergen as CFO - Feedstuffs
Transcript : Elanco Animal Health Incorporated Presents at Stifel Jaws & Paws Conference 2025, May-29-2025 08 - marketscreener.com
Elanco names Robert VanHimbergen as new CFO By Investing.com - Investing.com South Africa
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer - citybiz
How Elanco Plans on Winning in the Pet Wellness Boom - marketscreener.com
Elanco Animal Health Incorporated Announces Change of Executive Vice President - marketscreener.com
Elanco Animal Health Incorporated Reconfirms Earnings Guidance for the Second Quarter and Full Year 2025 - marketscreener.com
Elanco Animal Health Appoints Robert VanHimbergen As CFO, Reaffirms Q2, FY25 Guidance - Nasdaq
Elanco (ELAN) Names Robert VanHimbergen as New CFO | ELAN Stock News - GuruFocus
Elanco Animal Health (ELAN) Maintains Revenue and Earnings Outlook for Q2 | ELAN Stock News - GuruFocus
Elanco Animal Health (ELAN) Reaffirms FY25 Revenue and EBITDA Ou - GuruFocus
Elanco Appoints New CFO to Drive Growth - TipRanks
Elanco names Robert VanHimbergen as new CFO - Investing.com
Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer | ELAN Stock News - GuruFocus
Elanco Animal Health (ELAN) Reaffirms FY25 Revenue and EBITDA Outlook | ELAN Stock News - GuruFocus
Elanco Animal Health Inc (ELAN) 財務データ
収益
当期純利益
現金流量
EPS
0.23%
0.53%
大文字化:
|
ボリューム (24 時間):